Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion

Journal of Lipid Research

Volumn 55, Issue 12, 2015, Pages 2554-2561

  Schonewille, Marleen ^a   Brufau, Gemma ^a   Shiri Sverdlov, Ronit ^b   Groen, Albert K ^a   Plat, Jogchum ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chylomicrons; Liver; Phytosterols; Triglycerides; Very low density lipoprotein

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; CD68 ANTIGEN; CHYLOMICRON; INTERLEUKIN 1BETA; LIPOPROTEIN LIPASE; LIVER X RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYTOSTEROL; STANOL ESTER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN; ANTILIPEMIC AGENT; CHOLESTEROL; ESTER; SITOSTEROL DERIVATIVE;

ACACB GENE; ACOX1 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; CPT1A GENE; FATTY ACID OXIDATION; FOOD COMPOSITION; GENE; GENE EXPRESSION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DIET THERAPY; HYPERTRIGLYCERIDEMIA; LIVER; METABOLISM; POSTPRANDIAL STATE; REPRODUCIBILITY; SECRETION (PROCESS);

ANIMALS; CHOLESTEROL; CHYLOMICRONS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ESTERS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, VLDL; LIVER; MALE; MICE, INBRED C57BL; PHYTOSTEROLS; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; SITOSTEROLS; TRIGLYCERIDES;

EID: 84919740744     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M052407     Document Type: Article

References (42)

1. Wu, T., J. Fu, Y. Yang, L. Zhang, and J. Han. 2009. The effects of phytosterols/stanols on blood lipid profi les: a systematic review with meta-analysis. Asia Pac. J. Clin. Nutr. 18 : 179-186.
2. Brufau, G., M. A. Canela, and M. Rafecas. 2008. Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties. Nutr. Res. 28 : 217-225.
3. Calpe-Berdiel, L., J. C. Escola-Gil, and F. Blanco-Vaca. 2009. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis. 203 : 18-31.
4. De Smet, E., R. P. Mensink, and J. Plat. 2012. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol. Nutr. Food Res. 56 : 1058-1072.
5. Brufau, G., F. Kuipers, Y. Lin, E. A. Trautwein, and A. K. Groen. 2011. A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice. PLoS ONE. 6 : e21576.
6. Plat, J., G. Brufau, G. M. Dallinga-Thie, M. Dasselaar, and R. P. Mensink. 2009. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J. Nutr. 139 : 1143-1149.
7. Sialvera, T. E., G. D. Pounis, A. E. Koutelidakis, D. J. Richter, G. Yfanti, M. Kapsokefalou, G. Goumas, N. Chiotinis, E. Diamantopoulos, and A. Zampelas. 2012. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr. Metab. Cardiovasc. Dis. 22 : 843-848.
8. Naumann, E., J. Plat, A. D. Kester, and R. P. Mensink. 2008. The baseline serum lipoprotein profi le is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J. Am. Coll. Nutr. 27 : 117-126.
9. Demonty, I., R. T. Ras, H. C. van der Knaap, L. Meijer, P. L. Zock, J. M. Geleijnse, and E. A. Trautwein. 2013. The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials. Eur. J. Nutr. 52 : 153-160.
10. Rideout, T. C., S. V. Harding, and P. J. Jones. 2010. Consumption of plant sterols reduces plasma and hepatic triglycerides and modulates the expression of lipid regulatory genes and de novo lipogenesis in C57BL/6J mice. Mol. Nutr. Food Res. 54 (Suppl 1) : S7-S13.
11. Emerging Risk Factors Collaboration, E. Di Angelantonio, N. Sarwar, P. Perry, S. Kaptoge, K. K. Ray, A. Thompson, A. M. Wood, S. Lewington, N. Sattar, C. J. Packard, R. Collins, S. G. Thompson, and J. Danesh. 2009. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 302 : 1993-2000.
12. Nakajima, K., T. Nakano, Y. Tokita, T. Nagamine, A. Inazu, J. Kobayashi, H. Mabuchi, K. L. Stanhope, P. J. Havel, M. Okazaki, et al. 2011. Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin. Chim. Acta. 412 : 1306-1318.
13. Jackson, K. G., C. M. Walden, P. Murray, A. M. Smith, J. A. Lovegrove, A. M. Minihane, and C. M. Williams. 2012. A sequential two meal challenge reveals abnormalities in postprandial TAG but not glucose in men with increasing numbers of metabolic syndrome components. Atherosclerosis. 220 : 237-243.
14. Nordestgaard, B. G., M. Benn, P. Schnohr, and A. Tybjaerg-Hansen. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298 : 299-308.
15. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 : 911-917.
16. Gautier, T., U. J. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers. 2007. Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. J. Lipid Res. 48 : 30-40.
17. Grefhorst, A., B. M. Elzinga, P. J. Voshol, T. Plosch, T. Kok, V. W. Bloks, F. H. van der Sluijs, L. M. Havekes, J. A. Romijn, H. J. Verkade, et al. 2002. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277 : 34182-34190.
18. Plosch, T., V. W. Bloks, J. F. Baller, R. Havinga, H. J. Verkade, P. L. Jansen, and F. Kuipers. 2002. Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria. Hepatology. 35 : 299-306.
19. Stricker, D. 2008. BrightStat.com: free statistics online. Comput. Methods Programs Biomed. 92 : 135-143.
20. Othman, R. A., and M. H. Moghadasian. 2011. Beyond cholesterol-lowering effects of plant sterols: clinical and experimental evidence of anti-infl ammatory properties. Nutr. Rev. 69 : 371-382.
21. Grefhorst, A., and E. J. Parks. 2009. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice. J. Lipid Res. 50 : 1374-1383.
22. Kim, D. H., T. Zhang, S. Ringquist, and H. H. Dong. 2011. Targeting FoxO1 for hypertriglyceridemia. Curr. Drug Targets. 12 : 1245-1255.
23. Rakhshandehroo, M., B. Knoch, M. Muller, and S. Kersten. 2010. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010 : Epub. September 26, 2010. doi: 10.1155/2010/612089.
24. Plösch, T., J. K. Kruit, V. W. Bloks, N. C. Huijkman, R. Havinga, G. S. Duchateau, Y. Lin, and F. Kuipers. 2006. Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. J. Nutr. 136 : 2135-2140.
25. Calpe-Berdiel, L., J. C. Escola-Gil, V. Ribas, A. Navarro-Sastre, J. Garces-Garces, and F. Blanco-Vaca. 2005. Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis. 181 : 75-85.
26. Volger, O. L., H. van der Boom, E. C. de Wit, W. van Duyvenvoorde, G. Hornstra, J. Plat, L. M. Havekes, R. P. Mensink, and H. M. Princen. 2001. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E∗3-Leiden transgenic mice. Arterioscler. Thromb. Vasc. Biol. 21 : 1046-1052.
27. Ostlund, R. E., Jr. 2002. Phytosterols in human nutrition. Annu. Rev. Nutr. 22 : 533-549.
28. Gibbons, G. F., D. Wiggins, A. M. Brown, and A. M. Hebbachi. 2004. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32 : 59-64.
29. Adiels, M., M. R. Taskinen, C. Packard, M. J. Caslake, A. Soro- Paavonen, J. Westerbacka, S. Vehkavaara, A. Hakkinen, S. O. Olofsson, H. Yki-Jarvinen, et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 49 : 755-765.
30. Matikainen, N., M. R. Taskinen, S. Stennabb, N. Lundbom, A. Hakkarainen, K. Vaaralahti, and T. Raivio. 2012. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat. Eur. J. Endocrinol. 166 : 487 - 492.
31. Wiegman, C. H., R. H. Bandsma, M. Ouwens, F. H. van der Sluijs, R. Havinga, T. Boer, D. J. Reijngoud, J. A. Romijn, and F. Kuipers. 2003. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes. 52 : 1081-1089.
32. Grefhorst, A., J. Hoekstra, T. G. Derks, D. M. Ouwens, J. F. Baller, R. Havinga, L. M. Havekes, J. A. Romijn, and F. Kuipers. 2005. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. Am. J. Physiol. Gastrointest. Liver Physiol. 289 : G592-G598.
33. van Diepen, J. A., I. O. Vroegrijk, J. F. Berbee, S. E. Shoelson, J. A. Romijn, L. M. Havekes, P. C. Rensen, and P. J. Voshol. 2011. Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 301 : E1099-E1107.
34. Oosterveer, M. H., A. Grefhorst, A. K. Groen, and F. Kuipers. 2010. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design. Prog. Lipid Res. 49 : 343-352.
35. Basciano, H., A. Miller, C. Baker, M. Naples, and K. Adeli. 2009. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 297 : G323 - G332.
36. Zhou, J., M. Febbraio, T. Wada, Y. Zhai, R. Kuruba, J. He, J. H. Lee, S. Khadem, S. Ren, S. Li, et al. 2008. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 134 : 556-567.
37. Koonen, D. P., R. L. Jacobs, M. Febbraio, M. E. Young, C. L. Soltys, H. Ong, D. E. Vance, and J. R. Dyck. 2007. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 56 : 2863-2871.
38. VerHague, M. A., D. Cheng, R. B. Weinberg, and G. S. Shelness. 2013. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler. Thromb. Vasc. Biol. 33 : 2501-2508.
39. van der Veen, J. N., R. Havinga, V. W. Bloks, A. K. Groen, and F. Kuipers. 2007. Cholesterol feeding strongly reduces hepatic VLDLtriglyceride production in mice lacking the liver X receptor alpha. J. Lipid Res. 48 : 337-347.
40. Plat, J., J. A. Nichols, and R. P. Mensink. 2005. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J. Lipid Res. 46 : 2468-2476.
41. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60 : 473-485.
42. Nakajima, K., T. Nakano, Y. Tokita, T. Nagamine, S. Yatsuzuka, Y. Shimomura, A. Tanaka, H. Sumino, M. Nara, T. Machida, et al. 2012. The characteristics of remnant lipoproteins in the fasting and postprandial plasma. Clin. Chim. Acta. 413 : 1077-1086.